SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 309 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $62,043,000 | -14.2% | 539,787 | +16.6% | 3.30% | -14.4% |
| Q3 2014 | $72,313,000 | +1308.8% | 462,836 | +1012.3% | 3.86% | +1098.4% |
| Q2 2014 | $5,133,000 | +1.7% | 41,609 | -14.6% | 0.32% | -31.8% |
| Q1 2014 | $5,047,000 | +192.6% | 48,713 | +154.0% | 0.47% | +271.7% |
| Q4 2013 | $1,725,000 | – | 19,180 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $46,872,000 | 24.29% |
| HealthCor Management, L.P. | 935,100 | $146,100,000 | 7.50% |
| 1492 Capital Management LLC | 70,167 | $10,963,000 | 6.07% |
| Visium Asset Management, LP | 2,301,629 | $359,607,000 | 5.31% |
| HWG Holdings LP | 39,621 | $6,190,000 | 4.97% |
| Riggs Asset Managment Co. Inc. | 45,649 | $7,132,000 | 4.14% |
| Cardinal Capital Management | 49,139 | $7,677,000 | 3.65% |
| AMI ASSET MANAGEMENT CORP | 213,398 | $33,341,000 | 3.27% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 88,435 | $13,817,000 | 3.14% |
| Adamant Biomedical Investments AG | 78,210 | $12,220,000 | 3.05% |